Combination HIV Prevention: The Value and Interpretation of Mathematical Models

Por Walensky, Rochelle P.
Publicado em 2013

Cost-Effectiveness Analysis and HIV Screening: The Emergency Medicine Perspective

Por Hsu, Heather, Walensky, Rochelle P.
Publicado em 2011

HIV Self-testing and the Missing Linkage

Por Walensky, Rochelle P., Bassett, Ingrid V.
Publicado em 2011

Integrating HIV Screening into Routine Health Care in Resource-Limited Settings

Por Bassett, Ingrid V., Walensky, Rochelle P.
Publicado em 2010

Home HIV Testing: Good News but Not a Game Changer

Por Paltiel, A. David, Walensky, Rochelle P.
Publicado em 2012

Modeling and Cost-Effectiveness in HIV Prevention

Por Jacobsen, Margo M., Walensky, Rochelle P.
Publicado no Curr HIV/AIDS Rep (2016)

Implications and Impact of the Centers for Disease Control and Prevention (CDC) New HIV Testing Guidelines

Por Millen, Jennifer C., Arbelaez, Christian, Walensky, Rochelle P.
Publicado em 2008

Reply to Spellberg, Fuchs, and Manian

Por Walensky, Rochelle P, del Rio, Carlos, Armstrong, Wendy S
Publicado no Clin Infect Dis (2017)

Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV–tuberculosis coinfected populations

Por Cohen, Ted, Lipsitch, Marc, Walensky, Rochelle P., Murray, Megan
Publicado em 2006

Potential savings by reduced CD4 monitoring in stable HIV patients on antiretrovirals

Por Hyle, Emily P., Sax, Paul E., Walensky, Rochelle P.
Publicado em 2013

Misinterpretation of HIV Preexposure Prophylaxis Findings

Por Paltiel, A. David, Walensky, Rochelle P., Freedberg, Kenneth A.
Publicado no Clin Infect Dis (2014)

Integrating Social Contact and Environmental Data in Evaluating Tuberculosis Transmission in a South African Township

Por Andrews, Jason R., Morrow, Carl, Walensky, Rochelle P., Wood, Robin
Publicado em 2014

AIDS Drug Assistance Programs in the Era of Routine HIV Testing

Por Bassett, Ingrid V., Farel, Claire, Szmuilowicz, Emily D., Walensky, Rochelle P.
Publicado em 2008

Home Testing for HIV Infection in Resource-Limited Settings

Por Ganguli, Ishani, Bassett, Ingrid V., Dong, Krista L., Walensky, Rochelle P.
Publicado em 2009

Improving Clinical Outcomes in Patients With Methicillin-Sensitive Staphylococcus aureus Bacteremia and Reported Penicillin Allergy

Por Blumenthal, Kimberly G., Parker, Robert A., Shenoy, Erica S., Walensky, Rochelle P.
Publicado no Clin Infect Dis (2015)

Cost-Effectiveness of HIV Testing and Treatment in the United States

Por Walensky, Rochelle P., Freedberg, Kenneth A., Weinstein, Milton C., Paltiel, A. David
Publicado em 2007

Cost-effectiveness of Laboratory Monitoring in Sub-Saharan Africa: A Review of the Current Literature

Por Walensky, Rochelle P., Ciaranello, Andrea L., Park, Ji-Eun, Freedberg, Kenneth A.
Publicado em 2010

Expanded HIV Screening in the U.S.: What Will It Cost Government Discretionary and Entitlement Programs? A Budget Impact Analysis

Por Martin, Erika G., Paltiel, A. David, Walensky, Rochelle P., Schackman, Bruce R.
Publicado em 2010

Apparent Declining Efficacy in Randomized Trials: Examples oftheRV144 HIV Vaccine and CAPRISA 004 Microbicide Trials

Por O’HAGAN, Justin J., HERNÁN, Miguel A., WALENSKY, Rochelle P., LIPSITCH, Marc
Publicado em 2012

Resource Burden Associated with Contact Precautions for Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus: The Patient Access Managers' Perspective

Por Shenoy, Erica S., Walensky, Rochelle P., Lee, Hang, Orcutt, Benjamin, Hooper, David C.
Publicado em 2012